Luise Sophie Ammer
Overview
Explore the profile of Luise Sophie Ammer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ammer L, Tauber K, Perez A, Dohrmann T, Denecke J, Santer R, et al.
J Clin Med
. 2023 Jun;
12(12).
PMID: 37373807
Mucolipidosis type II (MLII), an ultra-rare lysosomal storage disorder, manifests as a fatal multi-systemic disease. Mental inhibition and progressive neurodegeneration are commonly reported disease manifestations. Nevertheless, longitudinal data on neurocognitive...
2.
Ammer L, Muschol N, Santer R, Lang A, Breyer S, Sasu P, et al.
J Clin Med
. 2022 Jul;
11(13).
PMID: 35806935
Mucolipidosis (ML) type II, intermediate, and III are lysosomal storage disorders with progressive multiorgan manifestations predisposing patients to a high risk of perioperative morbidity. The aims of the study were...
3.
Ammer L, Dohrmann T, Muschol N, Lang A, Breyer S, Ozga A, et al.
J Clin Med
. 2021 Aug;
10(16).
PMID: 34441814
Patients with mucopolysaccharidoses (MPS) frequently require anaesthesia for diagnostic or surgical interventions and thereby experience high morbidity. This study aimed to develop a multivariable prediction model for anaesthesia-related complications in...
4.
Ammer L, Pohl S, Breyer S, Aries C, Denecke J, Perez A, et al.
Mol Genet Metab Rep
. 2021 Jan;
26:100704.
PMID: 33505859
Background: Mucolipidosis type II (MLII) is an ultra-rare lysosomal storage disorder caused by defective lysosomal enzyme trafficking. Clinical hallmarks are craniofacial dysmorphia, cardiorespiratory dysfunction, hepatosplenomegaly, skeletal deformities and neurocognitive retardation....
5.
Ammer L, Oussoren E, Muschol N, Pohl S, Rubio-Gozalbo M, Santer R, et al.
J Clin Med
. 2020 Mar;
9(3).
PMID: 32182687
Mucolipidosis type II (MLII) is a rare lysosomal storage disorder caused by defective trafficking of lysosomal enzymes. Severe skeletal manifestations are a hallmark of the disease including hip dysplasia. This...